Lexaria Bioscience (LEXX) Change in Accured Expenses (2014 - 2026)
Lexaria Bioscience's Change in Accured Expenses came in at $167,768 for fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$334,819 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Over the trailing twelve months to May 31, 2026, Lexaria Bioscience reported Change in Accured Expenses of -$1.11 million; for FY2025 (ended Aug 31, 2025), it was $396,637, down 52.0% from FY2024.
- Going back by fiscal year, Change in Accured Expenses was $826,468 in FY2024 (+833.9%), $88,492 in FY2023 (+74.5%), $50,726 in FY2022 (+267.5%) and $13,803 in FY2021.
- The fiscal Q3 2026 figure represents the highest quarterly Change in Accured Expenses since fiscal Q2 2025.
- Business Quant data shows LEXX's Change in Accured Expenses at -$1.24 million (Q2 2026), -$37,613 (Q1 2026) and $4,787 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | 167,768.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 167,768.00 |
| Feb 28, 2026 | -1.24 Mn |
| Nov 30, 2025 | -37,613.00 |
| Aug 31, 2025 | 4,787.00 |
| May 31, 2025 | -334,819.00 |
| Feb 28, 2025 | 1.52 Mn |
| Nov 30, 2024 | -797,423.00 |
| Aug 31, 2024 | 937,621.00 |
| May 31, 2024 | 73,469.00 |
| Feb 29, 2024 | -43,649.00 |
| Nov 30, 2023 | -140,973.00 |
| Aug 31, 2023 | -783,646.00 |
| May 31, 2023 | 833,811.00 |
| Feb 28, 2023 | -52,115.00 |
| Nov 30, 2022 | 90,442.00 |
| Aug 31, 2022 | -5,626.00 |
| May 31, 2022 | 40,484.00 |
| Feb 28, 2022 | -72,951.00 |
| Nov 30, 2021 | 88,819.00 |
| Aug 31, 2021 | -73,178.00 |
API Access
Lexaria Bioscience Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();